• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high mRNA levels in clear cell renal cell carcinoma.缺氧诱导因子 (HIF)-脯氨酰羟化酶 3 (PHD3) 在透明细胞肾细胞癌中维持高 mRNA 水平。
J Biol Chem. 2019 Mar 8;294(10):3760-3771. doi: 10.1074/jbc.RA118.004902. Epub 2019 Jan 7.
2
Decreased prolyl hydroxylase 3 mRNA expression in oncocytomas compared with clear cell renal cell carcinoma.与透明细胞肾细胞癌相比,嗜酸细胞瘤中脯氨酰羟化酶 3 mRNA 表达降低。
Int J Biol Markers. 2020 Dec;35(4):80-86. doi: 10.1177/1724600820960478. Epub 2020 Oct 29.
3
Prolyl Hydroxylase 3 Knockdown Accelerates -Mutant Kidney Cancer Growth In Vivo.脯氨酰羟化酶 3 敲低加速体内突变型肾癌细胞生长。
Int J Mol Sci. 2021 Mar 11;22(6):2849. doi: 10.3390/ijms22062849.
4
Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma.缺氧诱导因子 (HIF)-非依赖表达机制及 HIF 脯氨酰羟化酶-3 在肾细胞癌中的新功能。
J Cancer Res Clin Oncol. 2014 Mar;140(3):503-13. doi: 10.1007/s00432-014-1593-7. Epub 2014 Jan 30.
5
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.缺氧、缺氧诱导转录因子与肾癌
Eur Urol. 2016 Apr;69(4):646-657. doi: 10.1016/j.eururo.2015.08.007. Epub 2015 Aug 19.
6
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.硒通过脯氨酰羟化酶 2 依赖性和 von Hippel-Lindau 非依赖性降解,抑制肾透明细胞癌细胞中低氧诱导因子 1 和 2α,从而抑制肿瘤生长。
BMC Cancer. 2012 Jul 17;12:293. doi: 10.1186/1471-2407-12-293.
7
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.缺氧诱导因子-1(HIF-1)通过诱导HIF-α-脯氨酰-4-羟化酶来促进其自身降解。
Biochem J. 2004 Aug 1;381(Pt 3):761-7. doi: 10.1042/BJ20040620.
8
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.在肾癌细胞中,因冯·希佩尔-林道肿瘤抑制基因功能缺失,缺氧诱导因子HIF-1α和HIF-2α在常氧条件下上调。
Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938.
9
The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.蛋白酪氨酸磷酸酶受体 J 型受透明细胞肾细胞癌中 pVHL-HIF 轴的调控。
J Pathol. 2013 Mar;229(4):525-34. doi: 10.1002/path.4107. Epub 2013 Jan 21.
10
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.低核表达的 HIF-羟化酶 PHD2/EGLN1 和 PHD3/EGLN3 与肾透明细胞癌患者无复发生存率差相关。
Cancer Med. 2024 Feb;13(3):e6998. doi: 10.1002/cam4.6998.

引用本文的文献

1
Belzutifan-Associated Hypoxia: A Review of the Novel Therapeutic, Proposed Mechanisms of Hypoxia, and Management Recommendations.贝佐替凡相关缺氧:新型疗法、缺氧的拟议机制及管理建议综述
Int J Mol Sci. 2025 Jul 23;26(15):7094. doi: 10.3390/ijms26157094.
2
Pseudohypoxia-Stabilized HIF2α Transcriptionally Inhibits , a Druggable Target in MELAS.假性低氧稳定的HIF2α转录抑制,MELAS中的一个可成药靶点。
Cells. 2025 Jul 15;14(14):1078. doi: 10.3390/cells14141078.
3
Comparison of single-cell long-read and short-read transcriptome sequencing via cDNA molecule matching: quality evaluation of the MAS-ISO-seq approach.通过cDNA分子匹配比较单细胞长读长和短读长转录组测序:MAS-ISO-seq方法的质量评估
NAR Genom Bioinform. 2025 Jul 4;7(3):lqaf089. doi: 10.1093/nargab/lqaf089. eCollection 2025 Sep.
4
LRRK2 reduces the sensitivity to TKI and PD-1 blockade in ccRCC via activating LPCAT1.LRRK2通过激活LPCAT1降低ccRCC对TKI和PD-1阻断的敏感性。
Oncogene. 2025 Mar 22. doi: 10.1038/s41388-025-03289-0.
5
Understanding Hypoxia-Driven Tumorigenesis: The Interplay of HIF1A, DNA Methylation, and Prolyl Hydroxylases in Head and Neck Squamous Cell Carcinoma.理解缺氧驱动的肿瘤发生:HIF1A、DNA 甲基化和脯氨酰羟化酶在头颈部鳞状细胞癌中的相互作用。
Int J Mol Sci. 2024 Jun 12;25(12):6495. doi: 10.3390/ijms25126495.
6
Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.低核表达的 HIF-羟化酶 PHD2/EGLN1 和 PHD3/EGLN3 与肾透明细胞癌患者无复发生存率差相关。
Cancer Med. 2024 Feb;13(3):e6998. doi: 10.1002/cam4.6998.
7
Epigenetic regulation during cancer transitions across 11 tumour types.癌症在 11 种肿瘤类型中的转移过程中的表观遗传调控。
Nature. 2023 Nov;623(7986):432-441. doi: 10.1038/s41586-023-06682-5. Epub 2023 Nov 1.
8
β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.β-连环蛋白通过长链非编码 RNA 稳定 HIF2,抑制静脉注射免疫球蛋白免疫治疗。
Front Immunol. 2023 Sep 8;14:1204907. doi: 10.3389/fimmu.2023.1204907. eCollection 2023.
9
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies.透明细胞肾细胞癌治疗的最新进展:新型生物标志物与靶向治疗
Cancers (Basel). 2023 Jun 16;15(12):3207. doi: 10.3390/cancers15123207.
10
In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma.上皮-间质转化和癌症干性作为透明细胞肾细胞癌预后标志物的体外和计算机模拟分析
Cancers (Basel). 2023 May 1;15(9):2586. doi: 10.3390/cancers15092586.

本文引用的文献

1
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.PT2385 治疗既往治疗的晚期透明细胞肾细胞癌患者的 I 期剂量递增试验:一种首创的缺氧诱导因子-2α拮抗剂。
J Clin Oncol. 2018 Mar 20;36(9):867-874. doi: 10.1200/JCO.2017.74.2627. Epub 2017 Dec 19.
2
JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension.JNK2 上调低氧诱导因子,促进低氧诱导的红细胞生成和肺动脉高压。
J Biol Chem. 2018 Jan 5;293(1):271-284. doi: 10.1074/jbc.RA117.000440. Epub 2017 Nov 8.
3
HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma.低氧诱导因子脯氨酰羟化酶PHD3调节透明细胞肾细胞癌中的翻译机制和葡萄糖代谢。
Cancer Metab. 2017 Jul 4;5:5. doi: 10.1186/s40170-017-0167-y. eCollection 2017.
4
The EGLN-HIF O-Sensing System: Multiple Inputs and Feedbacks.EGLN - HIF氧感知系统:多种输入与反馈
Mol Cell. 2017 Jun 15;66(6):772-779. doi: 10.1016/j.molcel.2017.06.002.
5
HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cells.低氧诱导因子1/2α介导缺氧诱导的人胰腺癌细胞中乳酸脱氢酶A的表达。
Oncotarget. 2017 Apr 11;8(15):24840-24852. doi: 10.18632/oncotarget.15266.
6
PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma.PI3K-mTORC2 而非 PI3K-mTORC1 调控神经母细胞瘤中 HIF2A/EPAS1 的转录和血管生成。
Cancer Res. 2015 Nov 1;75(21):4617-28. doi: 10.1158/0008-5472.CAN-15-0708. Epub 2015 Oct 2.
7
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.缺氧、缺氧诱导转录因子与肾癌
Eur Urol. 2016 Apr;69(4):646-657. doi: 10.1016/j.eururo.2015.08.007. Epub 2015 Aug 19.
8
Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27.缺氧诱导脯氨酰羟化酶PHD3通过降低p27的稳定性来维持癌细胞的生长。
Mol Cancer. 2015 Jul 30;14:143. doi: 10.1186/s12943-015-0410-5.
9
Cezanne regulates E2F1-dependent HIF2α expression.塞尚调节E2F1依赖性HIF2α表达。
J Cell Sci. 2015 Aug 15;128(16):3082-93. doi: 10.1242/jcs.168864. Epub 2015 Jul 6.
10
Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma.转录组和代谢组分析表明,HIF1α介导透明细胞肾细胞癌中肿瘤代谢的改变。
PLoS One. 2015 Apr 1;10(4):e0120649. doi: 10.1371/journal.pone.0120649. eCollection 2015.

缺氧诱导因子 (HIF)-脯氨酰羟化酶 3 (PHD3) 在透明细胞肾细胞癌中维持高 mRNA 水平。

Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high mRNA levels in clear cell renal cell carcinoma.

机构信息

From the Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520 Turku, Finland.

the Department of Medical Biochemistry, Faculty of Medicine, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland.

出版信息

J Biol Chem. 2019 Mar 8;294(10):3760-3771. doi: 10.1074/jbc.RA118.004902. Epub 2019 Jan 7.

DOI:10.1074/jbc.RA118.004902
PMID:30617181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6416423/
Abstract

Most clear cell renal cell carcinomas (ccRCCs) have inactivation of the von Hippel-Lindau tumor suppressor protein (pVHL), resulting in the accumulation of hypoxia-inducible factor α-subunits (HIF-α) and their downstream targets. HIF-2α expression is particularly high in ccRCC and is associated with increased ccRCC growth and aggressiveness. In the canonical HIF signaling pathway, HIF-prolyl hydroxylase 3 (PHD3) suppresses HIF-2α protein by post-translational hydroxylation under sufficient oxygen availability. Here, using immunoblotting and immunofluorescence staining, qRT-PCR, and siRNA-mediated gene silencing, we show that unlike in the canonical pathway, PHD3 silencing in ccRCC cells leads to down-regulation of HIF-2α protein and mRNA. Depletion of other PHD family members had no effect on HIF-2α expression, and PHD3 knockdown in non-RCC cells resulted in the expected increase in HIF-2α protein expression. Accordingly, PHD3 knockdown decreased HIF-2α target gene expression in ccRCC cells and expression was restored upon forced HIF-2α expression. The effect of PHD3 depletion was pinpointed to mRNA stability. In line with these results, a strong positive correlation of and mRNA expression in ccRCC tumors was detected. Our results suggest that in contrast to the known negative regulation of HIF-2α in most cell types, high PHD3 expression in ccRCC cells maintains elevated HIF-2α expression and that of its target genes, which may enhance kidney cancer aggressiveness.

摘要

大多数透明细胞肾细胞癌(ccRCC)存在抑癌基因 von Hippel-Lindau 蛋白(pVHL)失活,导致缺氧诱导因子α亚基(HIF-α)及其下游靶基因积累。HIF-2α在 ccRCC 中的表达特别高,与 ccRCC 的生长和侵袭性增加有关。在经典的 HIF 信号通路中,在氧气充足的情况下,HIF-脯氨酰羟化酶 3(PHD3)通过翻译后羟化作用抑制 HIF-2α 蛋白。在这里,我们通过免疫印迹、免疫荧光染色、qRT-PCR 和 siRNA 介导的基因沉默实验,表明与经典通路不同,在 ccRCC 细胞中沉默 PHD3 会导致 HIF-2α 蛋白和 mRNA 的下调。其他 PHD 家族成员的耗竭对 HIF-2α 的表达没有影响,而非 RCC 细胞中 PHD3 的敲低导致 HIF-2α 蛋白表达的预期增加。因此,PHD3 敲低降低了 ccRCC 细胞中 HIF-2α 靶基因的表达,而强制表达 HIF-2α 则恢复了其表达。PHD3 耗竭的影响主要在于 mRNA 稳定性。与这些结果一致,在 ccRCC 肿瘤中检测到 和 mRNA 表达的强烈正相关。我们的研究结果表明,与大多数细胞类型中已知的 HIF-2α 负调控相反,ccRCC 细胞中高 PHD3 表达维持了 HIF-2α 及其靶基因的高表达,这可能增强了肾癌的侵袭性。